GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Global Blood Therapeutics, Inc. (GBT) (NasdaqGS: GBT) to Pfizer Inc. (NYSE: PFE).

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, August 8, 2022
Information
Tags: 
Class Action Lawsuit, Professional Services, Legal, Company, Nasdaq, Sale, LLC, KSF, PFE, NYSE, GBT, Pfizer
Geotags: 
LOUISIANA, UNITED STATES, NORTH AMERICA
Stock Symbol: 
NASDAQ:GBT
Summary
Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Global Blood Therapeutics, Inc. (GBT) (NasdaqGS: GBT) to Pfizer Inc. (NYSE: PFE).
  • Under the terms of the proposed transaction, shareholders of GBT will receive $68.50 in cash for each share of GBT that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .


Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Global Blood Therapeutics, Inc. (GBT) (NasdaqGS: GBT) to Pfizer Inc. (NYSE: PFE). Under the terms of the proposed transaction, shareholders of GBT will receive $68.50 in cash for each share of GBT that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-gbt/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Copyright: 
Copyright Business Wire 2022